Johnson & Johnson to Acquire Momenta Pharmaceuticals for $6.5 Billion in Cash
The company is paying a big premium to expand its autoimmune disease treatment footprint.
Full Article
Johnson & Johnson to Acquire Momenta Pharmaceuticals for $6.5 Billion in Cash
Motley Fool
0 shares
1 views
You might like
Related news coverage
US stocks slide from record levels after Fed minutes reveal concern for economic recovery
Business Insider
· *US stocks slid on Wednesday as investors mulled the cautionary remarks from Federal Reserve officials.*
· *Federal Open..
Advertisement
More coverage
Momenta Pharmaceuticals spikes 70% after agreeing to $6.5 billion Johnson & Johnson takeover
· *Momenta Pharmaceuticals surged as much as 70% in early Wednesday trading after reaching an agreement to be acquired by Johnson..
Business Insider